Brick & Kyle Associates lowered its holdings in shares of Metlife Inc (NYSE:MET) by 6.4% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,900 shares of the financial services provider’s stock after selling 475 shares during the period. Brick & Kyle Associates’ holdings in Metlife were worth $347,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of the company. Geode Capital Management LLC raised its holdings in shares of Metlife by 7.4% during the 4th quarter. Geode Capital Management LLC now owns 12,421,536 shares of the financial services provider’s stock worth $509,344,000 after buying an additional 856,479 shares in the last quarter. Clearbridge Investments LLC raised its holdings in shares of Metlife by 2.9% during the 1st quarter. Clearbridge Investments LLC now owns 11,907,582 shares of the financial services provider’s stock worth $506,906,000 after buying an additional 332,510 shares in the last quarter. Norges Bank bought a new stake in Metlife during the 4th quarter worth $274,580,000. LSV Asset Management grew its position in Metlife by 1.0% during the 1st quarter. LSV Asset Management now owns 4,053,327 shares of the financial services provider’s stock worth $172,550,000 after acquiring an additional 41,324 shares during the last quarter. Finally, Jennison Associates LLC grew its position in Metlife by 1.3% during the 1st quarter. Jennison Associates LLC now owns 3,869,086 shares of the financial services provider’s stock worth $164,707,000 after acquiring an additional 51,272 shares during the last quarter. 75.73% of the stock is owned by institutional investors.
A number of brokerages recently weighed in on MET. Wells Fargo & Co set a $33.00 price objective on Matador Resources and gave the stock a “hold” rating in a research report on Thursday, July 11th. Barclays set a $34.00 price objective on DCP Midstream and gave the stock a “hold” rating in a research report on Wednesday, May 22nd. Citigroup lowered Barrick Gold to a “neutral” rating in a research report on Thursday, May 23rd. ValuEngine upgraded Yirendai from a “strong sell” rating to a “sell” rating in a research report on Friday, May 3rd. Finally, UBS Group boosted their price objective on Verisk Analytics from $106.00 to $111.00 and gave the stock a “sell” rating in a research report on Tuesday, April 9th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the company’s stock. Metlife has a consensus rating of “Hold” and a consensus target price of $50.73.
Shares of NYSE MET traded up $0.22 during trading on Friday, reaching $50.36. The company had a trading volume of 1,329,143 shares, compared to its average volume of 3,422,026. The company has a fifty day simple moving average of $49.56. Metlife Inc has a 12 month low of $37.76 and a 12 month high of $50.94. The company has a market cap of $47.88 billion, a PE ratio of 9.34, a P/E/G ratio of 1.09 and a beta of 1.10. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.24.
Metlife (NYSE:MET) last released its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.18. Metlife had a return on equity of 10.20% and a net margin of 7.56%. The firm had revenue of $15.45 billion for the quarter, compared to analyst estimates of $15.95 billion. During the same quarter in the previous year, the company posted $1.36 EPS. The business’s revenue was up 2.0% on a year-over-year basis. As a group, sell-side analysts forecast that Metlife Inc will post 5.59 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Tuesday, August 6th will be given a $0.44 dividend. The ex-dividend date of this dividend is Monday, August 5th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.49%. Metlife’s dividend payout ratio (DPR) is presently 32.65%.
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Featured Article: Cost of equity and a company’s balance sheet
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.